Personalization- The new norm for Pharma Marketing in the "New Normal" Gurpinder Singh18 May 2021 1:30 PM ISTCouple of years ago, I wrote an article "A Decade of Digital in Pharma", around my journey from being a Pharma Marketer to Marketer in the Digital...
"Brolucizumab - alterative for neovascular Age-related macular degeneration?", SHIFT study aswers Dr Ishan Kataria13 May 2021 6:45 PM ISTAge-related macular degeneration (AMD) is the leading cause of blindness in the elderly in industrialised countries. With the advent of ...
Teprotumumab: Drug to reduce asymmetry in thyroid eye disease Dr Ishan Kataria12 May 2021 6:15 AM ISTTeprotumumab, a specific blocking antibody to the insulin like growth factor 1 receptor, significantly reduced proptosis in patients with thyroid...
Hepatitis C Virus Drugs may augment Covid 19 suppression effect of Remdesevir: Study Dr Ishan Kataria8 May 2021 11:30 AM ISTEffective control of the SARS-CoV-2 coronavirus that causes COVID-19 requires antivirals. Considering the urgency to identify effective antiviral...
Letrozole- superior to clomiphene citrate for ovarian stimulation in PCOS patients Dr Nirali Kapoor3 May 2021 5:20 AM ISTResearchers have found in a new study that Letrozole is proving to hold a win- win response when it comes to anovulatory cycles in PCOS patients...
Anti- epileptic drug Valproic acid may be potential therapeutic option for Covid 19: Study Dr Ishan Kataria2 May 2021 10:26 PM ISTThe novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has posed a serious threat to the global public health. Respiratory failure,...
Treat your Vitamin D deficiency to strengthen your fight with Covid 19 Dr Ishan Kataria29 April 2021 7:45 AM ISTThe outbreak of COVID-19 has generated public health crisis at a global level.Infection provokes a remarkable range of responses from complete lack...
Dapagliflozin Reduces Blood Pressure by Vasodilation, Finds Study MD Bureau25 March 2021 7:58 PM ISTHypertension and type 2 diabetes mellitus (T2DM) are risk factors for cardiovascular disease. Dapagliflozin improves both blood sugar and systolic...
Dermatologists can now Prescribe Tofacitinib: CDSCO Committee MD Bureau19 Jan 2021 5:38 PM ISTNew Delhi: In the latest development Pfizer has earned approval from the Central Drugs Standard Control Organization (CDSCO) committee regarding the...
CDSCO Panel Gives Conditional nod to Azelnidipine and Olmesartan FDC MD Bureau18 Jan 2021 6:51 PM ISTNew Delhi: Following the submission of bioequivalence (BE) study report by Akum Drugs, the Central Drug Standard Control...
FDA Approves Berotralstat for Hereditary Angioedema prophylaxis MD Bureau4 Dec 2020 6:30 PM ISTThe US Food and Drug Administration has approved oral, once-daily ORLADEYOâ„¢ (berotralstat) for prophylaxis to prevent attacks of hereditary angioedema...
Glenmark receives DGCI approval for launching Favipiravir in India Dr. Kamal Kant Kohli21 Jun 2020 6:14 PM ISTGlenmark Pharmaceuticals has received approvals from Drug Controller General of India to manufacture and market Favipiravir, an anti-viral drug, to...
